APOEε2 is associated with milder clinical and pathological Alzheimer disease.
about
The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's diseaseParkinson Disease and Dementia.Apolipoprotein E and Sex Bias in Cerebrovascular Aging of Men and Mice.APOE Genotype Effects on Intrinsic Brain Network Connectivity in Patients with Amnestic Mild Cognitive Impairment.Protective effects of APOE e2 against disease progression in subcortical vascular mild cognitive impairment patients: A three-year longitudinal study.Enhanced Diabetes Susceptibility in Community Dwelling Han Elders Carrying the Apolipoprotein E 3/3 GenotypeAPOε2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: findings from the Nun StudyAPOE and cerebral amyloid angiopathy in community-dwelling older persons.Plaque-Associated Local Toxicity Increases over the Clinical Course of Alzheimer Disease.Impact of lifestyle dimensions on brain pathology and cognition.The role of APOE in cerebrovascular dysfunctionAPOE2 Is Associated with Spatial Navigational Strategies and Increased Gray Matter in the Hippocampus.Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's diseaseProtective effect of APOE epsilon 2 on intrinsic functional connectivity of the entorhinal cortex is associated with better episodic memory in elderly individuals with risk factors for Alzheimer's diseaseStudy of Exosomes Shed New Light on Physiology of Amyloidogenesis.Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.Alzheimer's Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function.APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations.Cyclic cis-Locked Phospho-Dipeptides Reduce Entry of AβPP into Amyloidogenic Processing Pathway.Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application.Cortical Thickness and Microstructural White Matter Changes Detect Amnestic Mild Cognitive Impairment.Differential Effects of APOE Genotypes on the Anterior and Posterior Subnetworks of Default Mode Network in Amnestic Mild Cognitive Impairment.Early Head Start, Pediatric Dental Use, and Oral Health-Related Quality of Life.The Association of Apolipoprotein E Gene Polymorphism With Cognitive Performance in Nondemented Polish Adults Aged 55 to 75.Deciphering the Astrocyte Reaction in Alzheimer's Disease.
P2860
Q26853347-FDB2D7F9-6581-4812-98C5-FCF283EBBBE4Q30248574-9DA08D62-76DB-426D-878F-39DE117F0FF9Q31122715-ED28BC25-B06A-49CB-AFA6-143ED1D69DB1Q33671934-C9F3A259-F64D-464C-86E4-AFDCDEAF891EQ33689543-763105F2-54C2-46CB-9793-4BB7DD219789Q35964648-AF0DF4F0-7A0B-4B81-A99D-CC9A8C8105E3Q35987278-F97421F3-159E-47D7-BAEF-24716EC4F69CQ36173680-F3F4C10A-6E75-4C4A-A049-BA8C5FA8039FQ36509219-44F7C4BE-B27A-4A12-97AA-AD22B055D54EQ36687806-166FA70E-80D8-4FDE-94E1-2E8C8802602BQ36813704-580A0408-8AE7-42DB-BF8E-5CE19429231FQ37089322-1269AF09-04D6-4354-96B8-D3936873E3BEQ37557940-0E3D2D13-0211-4F91-980F-013C31DE5B81Q37644772-A555CEE3-D261-4CF6-B3CC-5E8B836DFF3CQ38777380-E001B48E-3585-46A0-B178-2DA83AED2DF8Q38893744-701C6CA3-FCC0-48B1-AC17-B95DA94E6196Q39257249-5E753270-29CE-443D-861A-D04B981C3E66Q39873829-AE1D997F-0A03-41CD-9C55-B89E9461B407Q41010043-E3C1C716-6A0C-4F3E-AD67-82C59A8BD3A4Q41679990-1400EB8E-103C-4F11-932F-8D17DA8C8F25Q46158333-76DF6ECF-EF53-461B-B9E7-598D6899D994Q46535385-E5C339D2-C4BC-4ACE-9D94-698207F3E419Q48409043-220E4869-2002-476C-8810-39055DFED608Q48469056-2D6AB42B-4FB4-4F73-8577-B12D72C5A504Q49862227-0E5E0158-ED04-4F3E-B7F2-ADFEA299CEBCQ50564711-730B4297-F16A-41F9-BF87-55CBB2A6DAA6Q55364689-0621F28E-C74B-4528-B00E-DAB71022FE4A
P2860
APOEε2 is associated with milder clinical and pathological Alzheimer disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
APOEε2 is associated with milder clinical and pathological Alzheimer disease.
@ast
APOEε2 is associated with milder clinical and pathological Alzheimer disease.
@en
type
label
APOEε2 is associated with milder clinical and pathological Alzheimer disease.
@ast
APOEε2 is associated with milder clinical and pathological Alzheimer disease.
@en
prefLabel
APOEε2 is associated with milder clinical and pathological Alzheimer disease.
@ast
APOEε2 is associated with milder clinical and pathological Alzheimer disease.
@en
P2093
P2860
P356
P1433
P1476
APOEε2 is associated with milder clinical and pathological Alzheimer disease.
@en
P2093
Alberto Serrano-Pozo
Rebecca A Betensky
Sarah E Monsell
P2860
P304
P356
10.1002/ANA.24369
P577
2015-06-01T00:00:00Z